HIGROTCHotels & MotelsUS GAAP · USD

Hi-Great Group Holding Co

Hi-Great Group Holding Co is a development-stage U.S. holding company that has shifted away from CBD oils and is now focused on licensing and distributing niche consumer health products. Its current business plan centers on an exclusive worldwide license tied to the KRAS gene concept, the sale of SellaCare organic longevity supplements, and a planned expansion into cosmetics and herbal-based consumer products.

Revenue0.0m USD
−46.6 %y/y
Operating profit (EBIT)-0.1m USD
−76.1 %y/y
EBIT margin-236.0%
−164.4 ppy/y
Net income-0.1m USD
−79.4 %y/y

Fiscal year 2025 · change from previous year

Development 2020–2025

-0.2-0.10.00.10.20.3m USD2020: 0.19 m USD2020: EBIT -0.01 m USD20202021: 0.26 m USD2021: EBIT 0.00 m USD20212022: 0.21 m USD2022: EBIT 0.00 m USD20222023: 0.11 m USD2023: EBIT -0.12 m USD20232024: 0.07 m USD2024: EBIT -0.05 m USD20242025: 0.04 m USD2025: EBIT -0.09 m USD20250.04-0.09
RevenueOperating profit (EBIT)

Business

Share of revenue
Health supplements70 %

Organic longevity and wellness supplements marketed under the SellaCare license.

Licensing and IP-based initiatives10 %

Worldwide license arrangements and related commercialization concepts, including KRAS-related plans.

Cosmetics and personal care10 %

Planned expansion into cosmetic products using herbal oils and compounds.

Plant-based consumer products10 %

Finished consumer products built around specialty herbs and plant-based ingredients.

Customers

The company appears to sell to consumers seeking longevity, wellness, and herbal supplement products, with a planned extension into cosmetics buyers. Its licensing and product-distribution model suggests demand is driven by end users interested in niche health claims, natural ingredients, and alternative wellness positioning.

Wellness supplement consumers

Buy SellaCare longevity supplements for perceived health and longevity benefits.

Natural and organic product buyers

Purchase plant-based and specialty-herb products because they prefer natural ingredients.

Cosmetics and personal care consumers

Would buy herbal-oil and compound-based cosmetic products as the company expands.

Commercial license and distribution partners

Support product access, branding, and market reach through licensing or distribution arrangements.

Strategy

Management is trying to reposition the company around licensed wellness products, herbal consumer goods, and a future cosmetics platform after withdrawing CBD oils from the plan. The strategy depends on turning small-scale sales into a sustainable revenue base while preserving optionality across multiple consumer-health categories.

Commercialize licensed wellness productsShort term

The company needs a clearer revenue engine than its prior CBD-related plan.

Expand into cosmeticsMedium term

Cosmetics could broaden the addressable market and diversify product risk.

Build a sustainable multi-category platformMedium term

Management wants multiple revenue streams to reduce dependence on one product line.

Geography

The company is incorporated in Nevada and appears to operate primarily from the United States, with no disclosed country-by-country revenue split. Its business plan references a worldwide license and global commercialization ambitions, so future exposure could extend beyond the U.S. if product distribution scales.

Risks

The company remains development-stage, with very limited sales and recurring losses, so execution and financing risk are central. Its product plan also depends on licensing, regulatory acceptance, and consumer demand for wellness and cosmetic claims, which can be difficult to sustain in a small-cap business.

Sorted by severity
Liquidity and going-concern pressureHigh

The company has an accumulated deficit and small operating cash flows, so it may need external funding to continue.

Exposure: Operations and product development

Commercialization failureHigh

The business model depends on turning licensing and niche products into meaningful sales, which may not happen.

ExposureSellaCareKRAS-related planCosmetics expansion
Regulatory and product-claim riskMedium

Supplements and cosmetics can face scrutiny over marketing claims, ingredients, and compliance.

Exposure: Health supplements and cosmetic products

Dependence on third-party arrangementsMedium

The company relies on licenses, vendors, and service providers to execute its plan.

ExposureLicensingDistributionProfessional services

Accounting

Judgemental items
Revenue recognition on product sales and licenses

The company has limited sales and may also earn revenue from licensing or distribution arrangements, which can require judgment on timing and performance obligations.

Impact: Can shift revenue between periods and affect comparability

Equity issued for services

The company issued shares to a vendor in exchange for services, which requires valuation and expense recognition judgment.

Impact: Affects operating expenses and shareholders' equity

Contingencies and estimates

Management notes that contingencies and other estimates can materially affect reported amounts.

Impact: Can change liabilities, expenses, and net loss

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026